

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of cAMP-mediated signaling (GO:0043950) | 9.32521221 |
| 2 | angiotensin maturation (GO:0002003) | 8.39094841 |
| 3 | exploration behavior (GO:0035640) | 8.34070859 |
| 4 | neuronal stem cell maintenance (GO:0097150) | 8.29066731 |
| 5 | proline metabolic process (GO:0006560) | 7.64761518 |
| 6 | defense response to fungus (GO:0050832) | 7.51762139 |
| 7 | regulation of respiratory burst (GO:0060263) | 7.50171087 |
| 8 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 6.74997607 |
| 9 | endocrine pancreas development (GO:0031018) | 6.71992735 |
| 10 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 6.65095693 |
| 11 | acylglycerol homeostasis (GO:0055090) | 6.46777187 |
| 12 | triglyceride homeostasis (GO:0070328) | 6.46777187 |
| 13 | dentate gyrus development (GO:0021542) | 6.46465638 |
| 14 | regulation of guanylate cyclase activity (GO:0031282) | 6.26920859 |
| 15 | killing of cells of other organism (GO:0031640) | 6.07629246 |
| 16 | disruption of cells of other organism (GO:0044364) | 6.07629246 |
| 17 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 6.06328638 |
| 18 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 6.05436801 |
| 19 | positive regulation of respiratory burst (GO:0060267) | 5.72021455 |
| 20 | glutamine family amino acid biosynthetic process (GO:0009084) | 5.58105530 |
| 21 | positive regulation of digestive system process (GO:0060456) | 5.57436016 |
| 22 | digestive system process (GO:0022600) | 5.44311353 |
| 23 | membrane repolarization during action potential (GO:0086011) | 5.32472010 |
| 24 | intestinal absorption (GO:0050892) | 5.18551226 |
| 25 | negative regulation of glial cell proliferation (GO:0060253) | 5.11255004 |
| 26 | maintenance of gastrointestinal epithelium (GO:0030277) | 5.11149181 |
| 27 | potassium ion export (GO:0071435) | 5.04961759 |
| 28 | sequestering of metal ion (GO:0051238) | 5.04798300 |
| 29 | positive regulation of glucose transport (GO:0010828) | 5.01793569 |
| 30 | intestinal epithelial cell development (GO:0060576) | 4.99083254 |
| 31 | leukocyte migration involved in inflammatory response (GO:0002523) | 4.86624183 |
| 32 | regulation of cAMP-mediated signaling (GO:0043949) | 4.85498574 |
| 33 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.85448498 |
| 34 | positive regulation of pseudopodium assembly (GO:0031274) | 4.77813650 |
| 35 | hepatocyte apoptotic process (GO:0097284) | 4.76472139 |
| 36 | cardiovascular system development (GO:0072358) | 4.69983812 |
| 37 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 4.64995304 |
| 38 | response to fungus (GO:0009620) | 4.64724834 |
| 39 | complement activation, classical pathway (GO:0006958) | 4.61366348 |
| 40 | pentose-phosphate shunt (GO:0006098) | 4.60961169 |
| 41 | cell differentiation involved in embryonic placenta development (GO:0060706) | 4.58862254 |
| 42 | antimicrobial humoral response (GO:0019730) | 4.50926972 |
| 43 | antibacterial humoral response (GO:0019731) | 4.47473862 |
| 44 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.47215713 |
| 45 | endocrine process (GO:0050886) | 4.47215713 |
| 46 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.47215713 |
| 47 | glomerular filtration (GO:0003094) | 4.43174493 |
| 48 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.41176414 |
| 49 | lipoprotein transport (GO:0042953) | 4.40111978 |
| 50 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.34099067 |
| 51 | atrial cardiac muscle cell action potential (GO:0086014) | 4.34075866 |
| 52 | regulation of pseudopodium assembly (GO:0031272) | 4.28625654 |
| 53 | digestion (GO:0007586) | 4.27900474 |
| 54 | leukocyte aggregation (GO:0070486) | 4.25750222 |
| 55 | epoxygenase P450 pathway (GO:0019373) | 4.24590064 |
| 56 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.20873354 |
| 57 | NADPH regeneration (GO:0006740) | 4.17631472 |
| 58 | regulation of systemic arterial blood pressure (GO:0003073) | 4.08012499 |
| 59 | citrulline biosynthetic process (GO:0019240) | 4.05622831 |
| 60 | hormone catabolic process (GO:0042447) | 4.04420404 |
| 61 | renal filtration (GO:0097205) | 4.01868000 |
| 62 | cellular glucuronidation (GO:0052695) | 4.00807932 |
| 63 | cellular response to epinephrine stimulus (GO:0071872) | 4.00671487 |
| 64 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.99479690 |
| 65 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.99207915 |
| 66 | peptide catabolic process (GO:0043171) | 3.98006859 |
| 67 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.97510186 |
| 68 | uronic acid metabolic process (GO:0006063) | 3.96610773 |
| 69 | glucuronate metabolic process (GO:0019585) | 3.96610773 |
| 70 | long-term synaptic potentiation (GO:0060291) | 3.94538566 |
| 71 | transcytosis (GO:0045056) | 3.93997271 |
| 72 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.92886358 |
| 73 | ATP synthesis coupled proton transport (GO:0015986) | 3.83734366 |
| 74 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.83734366 |
| 75 | fructose metabolic process (GO:0006000) | 3.82333778 |
| 76 | urea cycle (GO:0000050) | 3.81125859 |
| 77 | urea metabolic process (GO:0019627) | 3.81125859 |
| 78 | regulation of cGMP biosynthetic process (GO:0030826) | 3.80311692 |
| 79 | epithelial structure maintenance (GO:0010669) | 3.78271171 |
| 80 | adhesion of symbiont to host cell (GO:0044650) | 3.77923111 |
| 81 | virion attachment to host cell (GO:0019062) | 3.77923111 |
| 82 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.75935355 |
| 83 | intestinal cholesterol absorption (GO:0030299) | 3.74772929 |
| 84 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.73883753 |
| 85 | peptide hormone processing (GO:0016486) | 3.69536368 |
| 86 | diacylglycerol metabolic process (GO:0046339) | 3.67883625 |
| 87 | complement activation (GO:0006956) | 3.67101199 |
| 88 | NADH metabolic process (GO:0006734) | 3.66976209 |
| 89 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.62042022 |
| 90 | cobalamin metabolic process (GO:0009235) | 3.58102336 |
| 91 | positive regulation of chemokine secretion (GO:0090197) | 3.56686702 |
| 92 | arginine metabolic process (GO:0006525) | 3.54696494 |
| 93 | positive regulation of insulin secretion (GO:0032024) | 3.54419028 |
| 94 | glycolipid catabolic process (GO:0019377) | 3.51212254 |
| 95 | cellular extravasation (GO:0045123) | 3.48497599 |
| 96 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.47774474 |
| 97 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.47774474 |
| 98 | membrane repolarization (GO:0086009) | 3.46372088 |
| 99 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.43469781 |
| 100 | L-serine transport (GO:0015825) | 3.42954749 |
| 101 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.41500227 |
| 102 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.41131857 |
| 103 | response to axon injury (GO:0048678) | 3.39589165 |
| 104 | nitrogen cycle metabolic process (GO:0071941) | 3.36318933 |
| 105 | glycosphingolipid catabolic process (GO:0046479) | 3.34906891 |
| 106 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.32315650 |
| 107 | bile acid and bile salt transport (GO:0015721) | 3.30942487 |
| 108 | regulation of vitamin metabolic process (GO:0030656) | 3.30688324 |
| 109 | renal system process involved in regulation of blood volume (GO:0001977) | 3.30259830 |
| 110 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.30182588 |
| 111 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.29203668 |
| 112 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 3.27256555 |
| 113 | regulation of chemokine secretion (GO:0090196) | 3.26454449 |
| 114 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 3.26250951 |
| 115 | primary alcohol metabolic process (GO:0034308) | 3.26101176 |
| 116 | GDP-mannose metabolic process (GO:0019673) | 3.25259919 |
| 117 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.23446612 |
| 118 | drug metabolic process (GO:0017144) | 3.15697420 |
| 119 | adhesion of symbiont to host (GO:0044406) | 3.13449361 |
| 120 | response to epinephrine (GO:0071871) | 3.12092251 |
| 121 | regulation of bile acid biosynthetic process (GO:0070857) | 3.11945967 |
| 122 | leukotriene biosynthetic process (GO:0019370) | 3.11261076 |
| 123 | regulation of cGMP metabolic process (GO:0030823) | 3.10519398 |
| 124 | eosinophil chemotaxis (GO:0048245) | 3.10478946 |
| 125 | galactose catabolic process (GO:0019388) | 3.09859721 |
| 126 | oligosaccharide biosynthetic process (GO:0009312) | 3.08485695 |
| 127 | O-glycan processing (GO:0016266) | 3.08250337 |
| 128 | diol metabolic process (GO:0034311) | 3.06162137 |
| 129 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.06039569 |
| 130 | glucose catabolic process (GO:0006007) | 3.05979291 |
| 131 | flavonoid metabolic process (GO:0009812) | 3.04104934 |
| 132 | * regulation of cellular extravasation (GO:0002691) | 3.01712008 |
| 133 | serine transport (GO:0032329) | 3.01430483 |
| 134 | vitamin A metabolic process (GO:0006776) | 3.01155780 |
| 135 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.00660937 |
| 136 | arginine catabolic process (GO:0006527) | 2.99778545 |
| 137 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.99524857 |
| 138 | eosinophil migration (GO:0072677) | 2.96464535 |
| 139 | cell killing (GO:0001906) | 2.94779776 |
| 140 | auditory receptor cell differentiation (GO:0042491) | 2.94430298 |
| 141 | cellular response to vitamin D (GO:0071305) | 2.93862542 |
| 142 | regulation of glial cell proliferation (GO:0060251) | 2.92701227 |
| 143 | regulation of triglyceride catabolic process (GO:0010896) | 2.89351146 |
| 144 | ethanol oxidation (GO:0006069) | 2.88984008 |
| 145 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.87509801 |
| 146 | leukotriene metabolic process (GO:0006691) | 2.86420148 |
| 147 | humoral immune response (GO:0006959) | 2.86243866 |
| 148 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.85328247 |
| 149 | detection of bacterium (GO:0016045) | 2.85165603 |
| 150 | ceramide catabolic process (GO:0046514) | 2.84429410 |
| 151 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.84042116 |
| 152 | phospholipid scrambling (GO:0017121) | 2.83368158 |
| 153 | regulation of interleukin-8 secretion (GO:2000482) | 2.82251851 |
| 154 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.81569990 |
| 155 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.80937251 |
| 156 | alkaloid metabolic process (GO:0009820) | 2.80189604 |
| 157 | positive regulation of cGMP biosynthetic process (GO:0030828) | 2.80155851 |
| 158 | sexual reproduction (GO:0019953) | 2.79786915 |
| 159 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.78387699 |
| 160 | plasma lipoprotein particle assembly (GO:0034377) | 2.77049419 |
| 161 | actin filament depolymerization (GO:0030042) | 2.76614277 |
| 162 | regulation of cholesterol homeostasis (GO:2000188) | 2.76052022 |
| 163 | midgut development (GO:0007494) | 2.75214877 |
| 164 | protein activation cascade (GO:0072376) | 2.73423258 |
| 165 | innate immune response in mucosa (GO:0002227) | 2.73403301 |
| 166 | secretion by tissue (GO:0032941) | 2.72985037 |
| 167 | chronic inflammatory response (GO:0002544) | 2.72819277 |
| 168 | positive regulation of peptide hormone secretion (GO:0090277) | 2.72236505 |
| 169 | positive regulation of peptide secretion (GO:0002793) | 2.61749236 |
| 170 | positive regulation of establishment of protein localization to plasma membrane (GO:0090004) | 2.59115367 |
| 171 | hexose catabolic process (GO:0019320) | 2.58800449 |
| 172 | oxidative phosphorylation (GO:0006119) | 2.57674256 |
| 173 | superoxide metabolic process (GO:0006801) | 2.56859172 |
| 174 | lipid homeostasis (GO:0055088) | 2.55282550 |
| 175 | negative regulation of interleukin-1 production (GO:0032692) | 2.54770824 |
| 176 | decidualization (GO:0046697) | 2.54394414 |
| 177 | primary alcohol catabolic process (GO:0034310) | 11.2581943 |
| 178 | proline biosynthetic process (GO:0006561) | 10.7606809 |
| 179 | ethanol metabolic process (GO:0006067) | 10.0486666 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 8.02045279 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 4.90582438 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.41462024 |
| 4 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 4.06315127 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.40040442 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.29311396 |
| 7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.92883488 |
| 8 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.92624815 |
| 9 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.88385979 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.88350548 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.81686488 |
| 12 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.81284338 |
| 13 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.72723774 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.69506587 |
| 15 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.65501302 |
| 16 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.20814801 |
| 17 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.18067558 |
| 18 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.15999616 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.12553714 |
| 20 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.10339709 |
| 21 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 2.08966722 |
| 22 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.05326124 |
| 23 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.01863789 |
| 24 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.96542136 |
| 25 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.94947580 |
| 26 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.87334952 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.77176249 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.73928625 |
| 29 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.73429529 |
| 30 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.71197870 |
| 31 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.66669521 |
| 32 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.65282737 |
| 33 | ATF3_27146783_Chip-Seq_COLON_Human | 1.63640057 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.59346767 |
| 35 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.56686173 |
| 36 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.56023741 |
| 37 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.55398585 |
| 38 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.53524862 |
| 39 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.51996968 |
| 40 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.48437398 |
| 41 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.47805471 |
| 42 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.46385026 |
| 43 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.44302555 |
| 44 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.43582193 |
| 45 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.42178136 |
| 46 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.40791092 |
| 47 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.39769798 |
| 48 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.38550766 |
| 49 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.38250471 |
| 50 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.37950400 |
| 51 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.37766645 |
| 52 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.36369288 |
| 53 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.35407992 |
| 54 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.35092644 |
| 55 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.32174817 |
| 56 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.27446631 |
| 57 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.27442064 |
| 58 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.26822498 |
| 59 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.24834480 |
| 60 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.23608036 |
| 61 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22242516 |
| 62 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.20645324 |
| 63 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.19150214 |
| 64 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.19025902 |
| 65 | P68_20966046_ChIP-Seq_HELA_Human | 1.18565927 |
| 66 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.18349682 |
| 67 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.18117873 |
| 68 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.17172251 |
| 69 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.16230630 |
| 70 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.15737318 |
| 71 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.15384134 |
| 72 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.15358591 |
| 73 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.14973873 |
| 74 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14555322 |
| 75 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.13710479 |
| 76 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13004865 |
| 77 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.12117013 |
| 78 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.11472833 |
| 79 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.10728084 |
| 80 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.10095996 |
| 81 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09601316 |
| 82 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.09090323 |
| 83 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.09077943 |
| 84 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.08584627 |
| 85 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.07106523 |
| 86 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.06792263 |
| 87 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06477029 |
| 88 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.05669174 |
| 89 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.04501471 |
| 90 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.04396597 |
| 91 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.03354918 |
| 92 | UTX_26944678_Chip-Seq_JUKART_Human | 1.01432193 |
| 93 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00640025 |
| 94 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.00524172 |
| 95 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99164786 |
| 96 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.98564632 |
| 97 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.98001787 |
| 98 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.97945304 |
| 99 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.97000062 |
| 100 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96692655 |
| 101 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.96055535 |
| 102 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.95796993 |
| 103 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.95796993 |
| 104 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.95459757 |
| 105 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.95182249 |
| 106 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95144449 |
| 107 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.95018479 |
| 108 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94859264 |
| 109 | GATA2_19941826_ChIP-Seq_K562_Human | 0.94680664 |
| 110 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.94641957 |
| 111 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.94041096 |
| 112 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.93735972 |
| 113 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.92720189 |
| 114 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90173787 |
| 115 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.89916752 |
| 116 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89229054 |
| 117 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.89190391 |
| 118 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.88329416 |
| 119 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88281518 |
| 120 | SA1_27219007_Chip-Seq_Bcells_Human | 0.88279839 |
| 121 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.88271182 |
| 122 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.88081458 |
| 123 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87966365 |
| 124 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.87949269 |
| 125 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.87923937 |
| 126 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.87199571 |
| 127 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.86872271 |
| 128 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.85772376 |
| 129 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.85684681 |
| 130 | GATA1_19941826_ChIP-Seq_K562_Human | 0.85325380 |
| 131 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.84572600 |
| 132 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.84008624 |
| 133 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.83843279 |
| 134 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.83723643 |
| 135 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.83691650 |
| 136 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83562475 |
| 137 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.82757155 |
| 138 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.80759158 |
| 139 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.79616400 |
| 140 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.78814216 |
| 141 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.78437401 |
| 142 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.78164630 |
| 143 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.77949139 |
| 144 | RXR_22108803_ChIP-Seq_LS180_Human | 0.77550300 |
| 145 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.76311200 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008004_abnormal_stomach_pH | 6.04931254 |
| 2 | MP0003123_paternal_imprinting | 4.98825989 |
| 3 | MP0005360_urolithiasis | 3.87656136 |
| 4 | MP0004264_abnormal_extraembryonic_tissu | 3.87147085 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 3.85442779 |
| 6 | MP0003300_gastrointestinal_ulcer | 3.84137135 |
| 7 | MP0000462_abnormal_digestive_system | 3.69665443 |
| 8 | MP0000490_abnormal_crypts_of | 3.63928500 |
| 9 | MP0003787_abnormal_imprinting | 3.56158458 |
| 10 | MP0010155_abnormal_intestine_physiology | 3.00514406 |
| 11 | MP0003866_abnormal_defecation | 2.99357059 |
| 12 | MP0000537_abnormal_urethra_morphology | 2.98913394 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.93408316 |
| 14 | MP0002139_abnormal_hepatobiliary_system | 2.83812449 |
| 15 | MP0004147_increased_porphyrin_level | 2.76533642 |
| 16 | MP0003806_abnormal_nucleotide_metabolis | 2.60900909 |
| 17 | MP0010352_gastrointestinal_tract_polyps | 2.59828785 |
| 18 | * MP0001663_abnormal_digestive_system | 2.37197553 |
| 19 | MP0001485_abnormal_pinna_reflex | 2.32524344 |
| 20 | MP0002876_abnormal_thyroid_physiology | 2.13733028 |
| 21 | MP0003693_abnormal_embryo_hatching | 2.04118819 |
| 22 | MP0003868_abnormal_feces_composition | 1.99473261 |
| 23 | MP0005085_abnormal_gallbladder_physiolo | 1.95536189 |
| 24 | MP0004858_abnormal_nervous_system | 1.94450797 |
| 25 | * MP0005381_digestive/alimentary_phenotyp | 1.94165985 |
| 26 | MP0005409_darkened_coat_color | 1.88962962 |
| 27 | MP0000477_abnormal_intestine_morphology | 1.87845685 |
| 28 | MP0003303_peritoneal_inflammation | 1.84736617 |
| 29 | MP0008872_abnormal_physiological_respon | 1.75570679 |
| 30 | MP0001664_abnormal_digestion | 1.63376261 |
| 31 | MP0003183_abnormal_peptide_metabolism | 1.59254507 |
| 32 | MP0004043_abnormal_pH_regulation | 1.56449888 |
| 33 | MP0002254_reproductive_system_inflammat | 1.54680557 |
| 34 | MP0003436_decreased_susceptibility_to | 1.42421640 |
| 35 | MP0002909_abnormal_adrenal_gland | 1.42390583 |
| 36 | MP0009785_altered_susceptibility_to | 1.39734342 |
| 37 | MP0009643_abnormal_urine_homeostasis | 1.38185547 |
| 38 | MP0005387_immune_system_phenotype | 1.35999098 |
| 39 | MP0001790_abnormal_immune_system | 1.35999098 |
| 40 | MP0003724_increased_susceptibility_to | 1.28988267 |
| 41 | MP0009379_abnormal_foot_pigmentation | 1.27774398 |
| 42 | MP0009840_abnormal_foam_cell | 1.25644418 |
| 43 | MP0001835_abnormal_antigen_presentation | 1.24775841 |
| 44 | MP0001348_abnormal_lacrimal_gland | 1.24506102 |
| 45 | MP0003828_pulmonary_edema | 1.23867984 |
| 46 | MP0005365_abnormal_bile_salt | 1.23363751 |
| 47 | MP0004019_abnormal_vitamin_homeostasis | 1.21527198 |
| 48 | * MP0001873_stomach_inflammation | 1.21098921 |
| 49 | MP0003191_abnormal_cellular_cholesterol | 1.20957695 |
| 50 | MP0003315_abnormal_perineum_morphology | 1.20155673 |
| 51 | MP0000470_abnormal_stomach_morphology | 1.18036273 |
| 52 | MP0003656_abnormal_erythrocyte_physiolo | 1.17069955 |
| 53 | MP0002136_abnormal_kidney_physiology | 1.15201147 |
| 54 | MP0002693_abnormal_pancreas_physiology | 1.13163797 |
| 55 | MP0003329_amyloid_beta_deposits | 1.06667152 |
| 56 | MP0010329_abnormal_lipoprotein_level | 1.06188355 |
| 57 | MP0005166_decreased_susceptibility_to | 1.04517927 |
| 58 | MP0002138_abnormal_hepatobiliary_system | 1.03070153 |
| 59 | MP0000613_abnormal_salivary_gland | 1.01733643 |
| 60 | MP0002118_abnormal_lipid_homeostasis | 1.01473072 |
| 61 | MP0003705_abnormal_hypodermis_morpholog | 1.00057672 |
| 62 | MP0005332_abnormal_amino_acid | 0.99383357 |
| 63 | MP0004957_abnormal_blastocyst_morpholog | 0.98844341 |
| 64 | MP0004782_abnormal_surfactant_physiolog | 0.98063189 |
| 65 | MP0002089_abnormal_postnatal_growth/wei | 0.97506509 |
| 66 | MP0008875_abnormal_xenobiotic_pharmacok | 0.96728863 |
| 67 | * MP0005025_abnormal_response_to | 0.94850548 |
| 68 | MP0002277_abnormal_respiratory_mucosa | 0.94777654 |
| 69 | MP0003252_abnormal_bile_duct | 0.93745277 |
| 70 | MP0001501_abnormal_sleep_pattern | 0.93257640 |
| 71 | MP0004947_skin_inflammation | 0.93250708 |
| 72 | MP0002098_abnormal_vibrissa_morphology | 0.92903572 |
| 73 | MP0003121_genomic_imprinting | 0.92711433 |
| 74 | MP0003453_abnormal_keratinocyte_physiol | 0.92191726 |
| 75 | MP0001764_abnormal_homeostasis | 0.91793923 |
| 76 | MP0001188_hyperpigmentation | 0.91403384 |
| 77 | MP0006082_CNS_inflammation | 0.91117496 |
| 78 | MP0000604_amyloidosis | 0.89472905 |
| 79 | MP0001851_eye_inflammation | 0.88525660 |
| 80 | MP0005670_abnormal_white_adipose | 0.87477714 |
| 81 | MP0002006_tumorigenesis | 0.87292147 |
| 82 | MP0002796_impaired_skin_barrier | 0.86909570 |
| 83 | MP0001849_ear_inflammation | 0.86632945 |
| 84 | MP0001800_abnormal_humoral_immune | 0.86577993 |
| 85 | * MP0001845_abnormal_inflammatory_respons | 0.85783693 |
| 86 | MP0004883_abnormal_blood_vessel | 0.85653101 |
| 87 | MP0002419_abnormal_innate_immunity | 0.84361761 |
| 88 | MP0005671_abnormal_response_to | 0.82998445 |
| 89 | MP0006054_spinal_hemorrhage | 0.82584706 |
| 90 | MP0005220_abnormal_exocrine_pancreas | 0.81384544 |
| 91 | MP0002166_altered_tumor_susceptibility | 0.80884075 |
| 92 | MP0009764_decreased_sensitivity_to | 0.79994857 |
| 93 | * MP0008469_abnormal_protein_level | 0.79521436 |
| 94 | MP0001533_abnormal_skeleton_physiology | 0.78710656 |
| 95 | MP0010386_abnormal_urinary_bladder | 0.78632411 |
| 96 | MP0005000_abnormal_immune_tolerance | 0.77878712 |
| 97 | MP0002971_abnormal_brown_adipose | 0.75853168 |
| 98 | MP0005451_abnormal_body_composition | 0.75361948 |
| 99 | MP0000230_abnormal_systemic_arterial | 0.75303258 |
| 100 | MP0002896_abnormal_bone_mineralization | 0.74923375 |
| 101 | MP0009333_abnormal_splenocyte_physiolog | 0.73109353 |
| 102 | MP0000249_abnormal_blood_vessel | 0.71329196 |
| 103 | MP0000678_abnormal_parathyroid_gland | 0.69790738 |
| 104 | MP0005165_increased_susceptibility_to | 0.69438237 |
| 105 | MP0009115_abnormal_fat_cell | 0.69325838 |
| 106 | MP0003045_fibrosis | 0.69092882 |
| 107 | MP0005319_abnormal_enzyme/_coenzyme | 0.68831351 |
| 108 | MP0005535_abnormal_body_temperature | 0.68135505 |
| 109 | MP0000681_abnormal_thyroid_gland | 0.67986526 |
| 110 | MP0000609_abnormal_liver_physiology | 0.67478000 |
| 111 | MP0006036_abnormal_mitochondrial_physio | 0.67157035 |
| 112 | MP0001881_abnormal_mammary_gland | 0.66747452 |
| 113 | MP0001765_abnormal_ion_homeostasis | 0.66688815 |
| 114 | MP0003879_abnormal_hair_cell | 0.66449819 |
| 115 | MP0002452_abnormal_antigen_presenting | 0.66330974 |
| 116 | MP0002998_abnormal_bone_remodeling | 0.65825540 |
| 117 | MP0002148_abnormal_hypersensitivity_rea | 0.65737923 |
| 118 | MP0005448_abnormal_energy_balance | 0.63001589 |
| 119 | MP0001944_abnormal_pancreas_morphology | 0.62687966 |
| 120 | MP0005310_abnormal_salivary_gland | 0.62581075 |
| 121 | MP0002405_respiratory_system_inflammati | 0.59536583 |
| 122 | MP0003075_altered_response_to | 0.58044815 |
| 123 | MP0005187_abnormal_penis_morphology | 0.57625147 |
| 124 | MP0001216_abnormal_epidermal_layer | 0.57115068 |
| 125 | MP0004484_altered_response_of | 0.56315031 |
| 126 | MP0000685_abnormal_immune_system | 0.56088801 |
| 127 | MP0003137_abnormal_impulse_conducting | 0.55822353 |
| 128 | MP0009765_abnormal_xenobiotic_induced | 0.55696318 |
| 129 | MP0002822_catalepsy | 0.55466996 |
| 130 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.55111819 |
| 131 | MP0005636_abnormal_mineral_homeostasis | 0.53431980 |
| 132 | MP0003566_abnormal_cell_adhesion | 0.52425376 |
| 133 | MP0000465_gastrointestinal_hemorrhage | 0.51987831 |
| 134 | MP0000538_abnormal_urinary_bladder | 0.51468607 |
| 135 | MP0000858_altered_metastatic_potential | 0.50883834 |
| 136 | MP0001756_abnormal_urination | 0.49696350 |
| 137 | MP0005464_abnormal_platelet_physiology | 0.48815232 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypercortisolism (HP:0001578) | 9.90616597 |
| 2 | Ventricular fibrillation (HP:0001663) | 8.77813149 |
| 3 | Congenital sensorineural hearing impairment (HP:0008527) | 7.51990553 |
| 4 | Posterior subcapsular cataract (HP:0007787) | 7.44940295 |
| 5 | Ileus (HP:0002595) | 6.22829426 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 5.56720816 |
| 7 | Late onset (HP:0003584) | 5.50152511 |
| 8 | Chorioretinal atrophy (HP:0000533) | 5.48058075 |
| 9 | Hydroxyprolinuria (HP:0003080) | 5.34072525 |
| 10 | Abnormality of proline metabolism (HP:0010907) | 5.34072525 |
| 11 | Fat malabsorption (HP:0002630) | 5.31628416 |
| 12 | Ketoacidosis (HP:0001993) | 4.89854487 |
| 13 | Chronic diarrhea (HP:0002028) | 4.80592428 |
| 14 | Adrenal overactivity (HP:0002717) | 4.75860231 |
| 15 | Subcapsular cataract (HP:0000523) | 4.35750966 |
| 16 | Steatorrhea (HP:0002570) | 4.23402054 |
| 17 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.96653175 |
| 18 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.96653175 |
| 19 | Decreased circulating renin level (HP:0003351) | 3.93599755 |
| 20 | Hyperactive renin-angiotensin system (HP:0000841) | 3.87540709 |
| 21 | Abdominal distention (HP:0003270) | 3.52535955 |
| 22 | Metabolic alkalosis (HP:0200114) | 3.51308673 |
| 23 | Glomerulonephritis (HP:0000099) | 3.39784216 |
| 24 | Syncope (HP:0001279) | 3.38027047 |
| 25 | Alkalosis (HP:0001948) | 3.28504781 |
| 26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.25532082 |
| 27 | Eczematoid dermatitis (HP:0000976) | 3.22122784 |
| 28 | Pustule (HP:0200039) | 3.20585888 |
| 29 | Ketosis (HP:0001946) | 3.20569388 |
| 30 | Abnormality of renin-angiotensin system (HP:0000847) | 3.18034314 |
| 31 | Micronodular cirrhosis (HP:0001413) | 3.14102838 |
| 32 | Abnormality of complement system (HP:0005339) | 3.08861578 |
| 33 | Rectal prolapse (HP:0002035) | 3.03631545 |
| 34 | Right ventricular cardiomyopathy (HP:0011663) | 3.01626788 |
| 35 | Complement deficiency (HP:0004431) | 3.00735790 |
| 36 | Villous atrophy (HP:0011473) | 2.99733194 |
| 37 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.99733194 |
| 38 | Thin bony cortex (HP:0002753) | 2.98792272 |
| 39 | Insulin resistance (HP:0000855) | 2.98628059 |
| 40 | Ankyloglossia (HP:0010296) | 2.93221276 |
| 41 | Ventricular arrhythmia (HP:0004308) | 2.88827750 |
| 42 | Hyperammonemia (HP:0001987) | 2.88217506 |
| 43 | Prolonged QT interval (HP:0001657) | 2.87596698 |
| 44 | Pancreatitis (HP:0001733) | 2.85176586 |
| 45 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.84382497 |
| 46 | Recurrent abscess formation (HP:0002722) | 2.84330896 |
| 47 | Pigmentary retinal degeneration (HP:0001146) | 2.84066030 |
| 48 | Nephritis (HP:0000123) | 2.75309959 |
| 49 | Symptomatic seizures (HP:0011145) | 2.71697134 |
| 50 | Abnormal biliary tract morphology (HP:0012440) | 2.70378290 |
| 51 | Exocrine pancreatic insufficiency (HP:0001738) | 2.66771361 |
| 52 | Hemorrhage of the eye (HP:0011885) | 2.65217453 |
| 53 | Recurrent bacterial skin infections (HP:0005406) | 2.64918046 |
| 54 | Bone cyst (HP:0012062) | 2.58024847 |
| 55 | Abnormal EKG (HP:0003115) | 2.57647888 |
| 56 | Hepatic necrosis (HP:0002605) | 2.57379319 |
| 57 | Increased muscle lipid content (HP:0009058) | 2.55345472 |
| 58 | Gingivitis (HP:0000230) | 2.51607793 |
| 59 | Hypoglycemic coma (HP:0001325) | 2.49680722 |
| 60 | Biliary tract neoplasm (HP:0100574) | 2.45419722 |
| 61 | Conjunctival hamartoma (HP:0100780) | 2.45124424 |
| 62 | Flat acetabular roof (HP:0003180) | 2.44542693 |
| 63 | Hypophosphatemia (HP:0002148) | 2.43452135 |
| 64 | Urticaria (HP:0001025) | 2.42709814 |
| 65 | Nephrolithiasis (HP:0000787) | 2.42233054 |
| 66 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.41223704 |
| 67 | Polar cataract (HP:0010696) | 2.41174754 |
| 68 | Hyperphosphatemia (HP:0002905) | 2.40739315 |
| 69 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.39083126 |
| 70 | Potter facies (HP:0002009) | 2.36416246 |
| 71 | Facial shape deformation (HP:0011334) | 2.36416246 |
| 72 | Neoplasm of the rectum (HP:0100743) | 2.35738388 |
| 73 | Proximal tubulopathy (HP:0000114) | 2.34495438 |
| 74 | Esophageal varix (HP:0002040) | 2.34262825 |
| 75 | Hyperuricemia (HP:0002149) | 2.33208449 |
| 76 | Increased purine levels (HP:0004368) | 2.33208449 |
| 77 | Hepatocellular necrosis (HP:0001404) | 2.32494608 |
| 78 | Gastrointestinal dysmotility (HP:0002579) | 2.30112641 |
| 79 | Hypotension (HP:0002615) | 2.28650176 |
| 80 | Neoplasm of the small intestine (HP:0100833) | 2.25779929 |
| 81 | Abnormality of vitamin B metabolism (HP:0004340) | 2.25578838 |
| 82 | Abnormality of oral frenula (HP:0000190) | 2.24533084 |
| 83 | Xanthomatosis (HP:0000991) | 2.24518744 |
| 84 | Cheilitis (HP:0100825) | 2.22056455 |
| 85 | Hypobetalipoproteinemia (HP:0003563) | 2.19613522 |
| 86 | Premature loss of primary teeth (HP:0006323) | 2.17365434 |
| 87 | Poikiloderma (HP:0001029) | 2.16352623 |
| 88 | Increased intramyocellular lipid droplets (HP:0012240) | 2.16259457 |
| 89 | Periodontitis (HP:0000704) | 2.15590479 |
| 90 | Trismus (HP:0000211) | 2.15012407 |
| 91 | Focal segmental glomerulosclerosis (HP:0000097) | 2.14771794 |
| 92 | Cerebral palsy (HP:0100021) | 2.13403172 |
| 93 | Hyperglycinuria (HP:0003108) | 2.12611473 |
| 94 | Abnormality of chloride homeostasis (HP:0011422) | 2.07738942 |
| 95 | Palpitations (HP:0001962) | 2.05813410 |
| 96 | Abnormality of the gastric mucosa (HP:0004295) | 2.04656052 |
| 97 | Multifactorial inheritance (HP:0001426) | 2.01975697 |
| 98 | Glycosuria (HP:0003076) | 1.99597635 |
| 99 | Abnormality of urine glucose concentration (HP:0011016) | 1.99597635 |
| 100 | Abnormal glucose tolerance (HP:0001952) | 1.99163278 |
| 101 | Abnormality of nucleobase metabolism (HP:0010932) | 1.98003588 |
| 102 | Wide cranial sutures (HP:0010537) | 1.95695382 |
| 103 | Progressive hearing impairment (HP:0001730) | 1.95217313 |
| 104 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.95004769 |
| 105 | Abnormality of glycine metabolism (HP:0010895) | 1.95004769 |
| 106 | Enlarged epiphyses (HP:0010580) | 1.94017481 |
| 107 | Uterine neoplasm (HP:0010784) | 1.93672527 |
| 108 | Renal tubular acidosis (HP:0001947) | 1.93191755 |
| 109 | Dicarboxylic aciduria (HP:0003215) | 1.92010556 |
| 110 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.92010556 |
| 111 | Malnutrition (HP:0004395) | 1.91307794 |
| 112 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.91063130 |
| 113 | Gout (HP:0001997) | 1.90584329 |
| 114 | Intrahepatic cholestasis (HP:0001406) | 1.89377728 |
| 115 | Protuberant abdomen (HP:0001538) | 1.88609273 |
| 116 | Abnormality of the nasal mucosa (HP:0000433) | 1.87904837 |
| 117 | Growth hormone excess (HP:0000845) | 1.87226844 |
| 118 | Abnormality of macrophages (HP:0004311) | 1.87166930 |
| 119 | Conjugated hyperbilirubinemia (HP:0002908) | 1.86991616 |
| 120 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.86118083 |
| 121 | Petechiae (HP:0000967) | 1.85203145 |
| 122 | Abnormality of vitamin metabolism (HP:0100508) | 1.84506066 |
| 123 | Delayed epiphyseal ossification (HP:0002663) | 1.84249425 |
| 124 | Dehydration (HP:0001944) | 1.83566727 |
| 125 | Vasculitis (HP:0002633) | 1.83144477 |
| 126 | Gastrointestinal stroma tumor (HP:0100723) | 1.79587312 |
| 127 | Microretrognathia (HP:0000308) | 1.79325989 |
| 128 | Colitis (HP:0002583) | 1.78913304 |
| 129 | Pili torti (HP:0003777) | 1.78565821 |
| 130 | Hyperaldosteronism (HP:0000859) | 1.78481724 |
| 131 | Emphysema (HP:0002097) | 1.78454240 |
| 132 | Bone pain (HP:0002653) | 1.78045156 |
| 133 | Hyperparathyroidism (HP:0000843) | 1.75616393 |
| 134 | Increased mean platelet volume (HP:0011877) | 1.75548804 |
| 135 | Skin rash (HP:0000988) | 1.74984777 |
| 136 | Acanthocytosis (HP:0001927) | 1.74166186 |
| 137 | Hypokalemia (HP:0002900) | 1.73891705 |
| 138 | Confusion (HP:0001289) | 1.73648681 |
| 139 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.72303504 |
| 140 | Vacuolated lymphocytes (HP:0001922) | 1.72093447 |
| 141 | Abnormality of purine metabolism (HP:0004352) | 1.71586002 |
| 142 | Widely patent fontanelles and sutures (HP:0004492) | 1.71401406 |
| 143 | Lethargy (HP:0001254) | 1.71020074 |
| 144 | Inflammation of the large intestine (HP:0002037) | 1.70979473 |
| 145 | Hypolipoproteinemia (HP:0010981) | 1.70594922 |
| 146 | Mitochondrial inheritance (HP:0001427) | 1.70563982 |
| 147 | Glomerulosclerosis (HP:0000096) | 1.70415154 |
| 148 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.70362020 |
| 149 | Abnormal tarsal ossification (HP:0008369) | 1.70101186 |
| 150 | Hyperbilirubinemia (HP:0002904) | 1.69704947 |
| 151 | Acute encephalopathy (HP:0006846) | 1.69314544 |
| 152 | Gastrointestinal inflammation (HP:0004386) | 1.68376676 |
| 153 | Neoplasm of the colon (HP:0100273) | 1.66112405 |
| 154 | Nausea (HP:0002018) | 1.65575515 |
| 155 | Xerostomia (HP:0000217) | 1.65074679 |
| 156 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.64682103 |
| 157 | Abnormal platelet volume (HP:0011876) | 1.64541564 |
| 158 | Fragile skin (HP:0001030) | 1.62837260 |
| 159 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.61522616 |
| 160 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.60310469 |
| 161 | Gastrointestinal carcinoma (HP:0002672) | 1.58980772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LMTK2 | 6.33622467 |
| 2 | ACVR1B | 5.23188194 |
| 3 | MAP2K6 | 4.43604433 |
| 4 | MAP2K2 | 4.14932825 |
| 5 | PRKG2 | 3.13444888 |
| 6 | NME1 | 2.53144681 |
| 7 | EPHA3 | 2.39932819 |
| 8 | SCYL2 | 2.38190841 |
| 9 | MST1R | 2.31402939 |
| 10 | PKN2 | 2.31029408 |
| 11 | PIK3CA | 2.28589924 |
| 12 | FRK | 2.28194716 |
| 13 | GRK6 | 2.22574058 |
| 14 | TYK2 | 2.17803814 |
| 15 | PTK6 | 2.17168662 |
| 16 | TESK1 | 2.13726078 |
| 17 | MAP3K2 | 1.96636457 |
| 18 | MAPK15 | 1.94694778 |
| 19 | BLK | 1.85024955 |
| 20 | TRIB3 | 1.81724523 |
| 21 | STK24 | 1.76038492 |
| 22 | PTK2 | 1.66482694 |
| 23 | PAK4 | 1.65808460 |
| 24 | EPHB1 | 1.64689700 |
| 25 | STK39 | 1.60991462 |
| 26 | IRAK4 | 1.55305824 |
| 27 | MAP3K10 | 1.53012274 |
| 28 | MAP3K12 | 1.51715486 |
| 29 | PRPF4B | 1.45566165 |
| 30 | ERN1 | 1.45210276 |
| 31 | MAP3K11 | 1.44723152 |
| 32 | PDK2 | 1.43663274 |
| 33 | NME2 | 1.36944150 |
| 34 | FGFR3 | 1.36222540 |
| 35 | DDR2 | 1.36069585 |
| 36 | MAP3K3 | 1.33654522 |
| 37 | MST4 | 1.33200414 |
| 38 | CDC42BPA | 1.30074208 |
| 39 | BUB1 | 1.27983275 |
| 40 | NLK | 1.24889565 |
| 41 | RPS6KB2 | 1.24592683 |
| 42 | RIPK1 | 1.20029248 |
| 43 | KSR2 | 1.16560007 |
| 44 | MAP4K1 | 1.13101120 |
| 45 | BCKDK | 1.09170423 |
| 46 | RIPK4 | 1.09144656 |
| 47 | FER | 1.07474160 |
| 48 | MAP3K8 | 1.05846256 |
| 49 | CAMK2B | 1.05060262 |
| 50 | DAPK2 | 1.03036821 |
| 51 | JAK1 | 1.02242441 |
| 52 | MAP2K1 | 1.01971036 |
| 53 | VRK1 | 1.00843355 |
| 54 | IRAK1 | 1.00764258 |
| 55 | MAP3K14 | 0.97870831 |
| 56 | TESK2 | 0.95915840 |
| 57 | PIM2 | 0.95084863 |
| 58 | WNK4 | 0.94607876 |
| 59 | TAOK3 | 0.92861346 |
| 60 | ZAP70 | 0.91469886 |
| 61 | NEK2 | 0.91388192 |
| 62 | STK10 | 0.89836886 |
| 63 | CAMK2D | 0.87675419 |
| 64 | LRRK2 | 0.86116138 |
| 65 | TTK | 0.85743678 |
| 66 | EPHA2 | 0.83308332 |
| 67 | IKBKE | 0.81963119 |
| 68 | TGFBR2 | 0.81505415 |
| 69 | MAPK11 | 0.80448482 |
| 70 | CAMK2G | 0.77471225 |
| 71 | TNIK | 0.77126507 |
| 72 | OXSR1 | 0.76672727 |
| 73 | MAP3K1 | 0.75190420 |
| 74 | DYRK1B | 0.74029419 |
| 75 | BMPR2 | 0.73099434 |
| 76 | TBK1 | 0.72840685 |
| 77 | TAOK1 | 0.71889936 |
| 78 | CSK | 0.71775465 |
| 79 | AURKB | 0.70619604 |
| 80 | MAPK4 | 0.70340569 |
| 81 | PBK | 0.69094541 |
| 82 | NEK1 | 0.68621354 |
| 83 | JAK2 | 0.64682374 |
| 84 | KIT | 0.64582197 |
| 85 | ERBB2 | 0.63986607 |
| 86 | JAK3 | 0.63684104 |
| 87 | PRKAA2 | 0.62485209 |
| 88 | IRAK3 | 0.61827836 |
| 89 | CAMKK1 | 0.60875686 |
| 90 | FGFR4 | 0.59977751 |
| 91 | PAK1 | 0.59004026 |
| 92 | MET | 0.58295836 |
| 93 | TTN | 0.55479726 |
| 94 | NUAK1 | 0.54765879 |
| 95 | RET | 0.53437614 |
| 96 | RAF1 | 0.52897751 |
| 97 | MYLK | 0.52192745 |
| 98 | GRK1 | 0.51968248 |
| 99 | PRKCD | 0.51486512 |
| 100 | PRKCQ | 0.49598357 |
| 101 | PDGFRA | 0.48597228 |
| 102 | FES | 0.48499076 |
| 103 | YES1 | 0.48134366 |
| 104 | LIMK1 | 0.47803237 |
| 105 | MAP2K3 | 0.46530536 |
| 106 | CDK19 | 0.46150519 |
| 107 | TLK1 | 0.44989570 |
| 108 | MAP3K9 | 0.44482834 |
| 109 | PDPK1 | 0.42119715 |
| 110 | KDR | 0.42097918 |
| 111 | BMX | 0.41919633 |
| 112 | FYN | 0.40918180 |
| 113 | LYN | 0.40400965 |
| 114 | TRPM7 | 0.40338427 |
| 115 | AKT3 | 0.37592718 |
| 116 | SYK | 0.36660347 |
| 117 | EPHB2 | 0.35464179 |
| 118 | BTK | 0.35088955 |
| 119 | DMPK | 0.34968000 |
| 120 | PRKCZ | 0.34828580 |
| 121 | EEF2K | 0.33139030 |
| 122 | ILK | 0.32831891 |
| 123 | MATK | 0.32659077 |
| 124 | SMG1 | 0.31536678 |
| 125 | ITK | 0.30631751 |
| 126 | HIPK2 | 0.30400885 |
| 127 | SRC | 0.29163073 |
| 128 | PRKCA | 0.28159838 |
| 129 | MAPKAPK2 | 0.27900734 |
| 130 | ABL2 | 0.27648387 |
| 131 | CSF1R | 0.26445068 |
| 132 | PRKCI | 0.26377457 |
| 133 | PRKACG | 0.26003904 |
| 134 | CDK6 | 0.24865922 |
| 135 | MAPK7 | 0.24853754 |
| 136 | STK11 | 0.24528092 |
| 137 | TEC | 0.24225931 |
| 138 | LCK | 0.24224615 |
| 139 | PASK | 0.23876600 |
| 140 | IGF1R | 0.22019001 |
| 141 | CDK11A | 0.21372663 |
| 142 | FGR | 0.21206096 |
| 143 | PRKCB | 0.20857990 |
| 144 | CDK15 | 0.20311314 |
| 145 | PDK1 | 0.19708143 |
| 146 | RPS6KA2 | 0.19089620 |
| 147 | PIK3CG | 0.18879760 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 5.40725576 |
| 2 | Histidine metabolism_Homo sapiens_hsa00340 | 4.08454524 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.99921194 |
| 4 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.93125925 |
| 5 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.77244343 |
| 6 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 2.95221632 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.80172459 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.62112966 |
| 9 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.60147586 |
| 10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.44062216 |
| 11 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 2.30963224 |
| 12 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.13641052 |
| 13 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.12623824 |
| 14 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.10217168 |
| 15 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.09491451 |
| 16 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.93697586 |
| 17 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.93219422 |
| 18 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.88692023 |
| 19 | Asthma_Homo sapiens_hsa05310 | 1.87666903 |
| 20 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.86478628 |
| 21 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.79580198 |
| 22 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.77737682 |
| 23 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.68958348 |
| 24 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.68936634 |
| 25 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.52058741 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.52021725 |
| 27 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.50266188 |
| 28 | Carbon metabolism_Homo sapiens_hsa01200 | 1.37592611 |
| 29 | Parkinsons disease_Homo sapiens_hsa05012 | 1.35237574 |
| 30 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.33569283 |
| 31 | Allograft rejection_Homo sapiens_hsa05330 | 1.31381857 |
| 32 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.30069343 |
| 33 | Leishmaniasis_Homo sapiens_hsa05140 | 1.29637093 |
| 34 | Insulin secretion_Homo sapiens_hsa04911 | 1.29400506 |
| 35 | Galactose metabolism_Homo sapiens_hsa00052 | 1.26817038 |
| 36 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.23671754 |
| 37 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.17317112 |
| 38 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.16924667 |
| 39 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.15376849 |
| 40 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.10993410 |
| 41 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.07841326 |
| 42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.04163313 |
| 43 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.03956055 |
| 44 | Lysine degradation_Homo sapiens_hsa00310 | 1.03577978 |
| 45 | Alzheimers disease_Homo sapiens_hsa05010 | 0.98561248 |
| 46 | Hepatitis C_Homo sapiens_hsa05160 | 0.96399418 |
| 47 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.93285398 |
| 48 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.93272309 |
| 49 | Bladder cancer_Homo sapiens_hsa05219 | 0.92608528 |
| 50 | Tight junction_Homo sapiens_hsa04530 | 0.88930753 |
| 51 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.88518734 |
| 52 | Pertussis_Homo sapiens_hsa05133 | 0.88412135 |
| 53 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.86532775 |
| 54 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.85643019 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.84415739 |
| 56 | Mineral absorption_Homo sapiens_hsa04978 | 0.82666053 |
| 57 | Salmonella infection_Homo sapiens_hsa05132 | 0.80035974 |
| 58 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.79403367 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76510920 |
| 60 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.76475322 |
| 61 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.73805219 |
| 62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.71104747 |
| 63 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.71071128 |
| 64 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.69888103 |
| 65 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.69194417 |
| 66 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.68542226 |
| 67 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.67543109 |
| 68 | Huntingtons disease_Homo sapiens_hsa05016 | 0.64610139 |
| 69 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.63925869 |
| 70 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63875142 |
| 71 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.63870032 |
| 72 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.60884200 |
| 73 | Bile secretion_Homo sapiens_hsa04976 | 0.59229635 |
| 74 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.56514513 |
| 75 | Shigellosis_Homo sapiens_hsa05131 | 0.56410100 |
| 76 | Other glycan degradation_Homo sapiens_hsa00511 | 0.54239092 |
| 77 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.51366396 |
| 78 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50136424 |
| 79 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.49390659 |
| 80 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.47779323 |
| 81 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.47474473 |
| 82 | Sulfur relay system_Homo sapiens_hsa04122 | 0.46709384 |
| 83 | Viral myocarditis_Homo sapiens_hsa05416 | 0.46055784 |
| 84 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.42617315 |
| 85 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.42270066 |
| 86 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.42129093 |
| 87 | ABC transporters_Homo sapiens_hsa02010 | 0.40956448 |
| 88 | Renin secretion_Homo sapiens_hsa04924 | 0.39053867 |
| 89 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.38051161 |
| 90 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.36289640 |
| 91 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.35899661 |
| 92 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.35015544 |
| 93 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.34817397 |
| 94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34770823 |
| 95 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.33062187 |
| 96 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.32684483 |
| 97 | Metabolic pathways_Homo sapiens_hsa01100 | 0.32109447 |
| 98 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.31012874 |
| 99 | Legionellosis_Homo sapiens_hsa05134 | 0.30554178 |
| 100 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.30390504 |
| 101 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.30321527 |
| 102 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.30171100 |
| 103 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.29819792 |
| 104 | DNA replication_Homo sapiens_hsa03030 | 0.28668711 |
| 105 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.28592130 |
| 106 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.28177935 |
| 107 | Influenza A_Homo sapiens_hsa05164 | 0.27955623 |
| 108 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.27766567 |
| 109 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.27101787 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.25888962 |
| 111 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25624208 |
| 112 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24570726 |
| 113 | Tuberculosis_Homo sapiens_hsa05152 | 0.23317287 |
| 114 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.22028321 |
| 115 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.21872876 |
| 116 | Amoebiasis_Homo sapiens_hsa05146 | 0.21720784 |
| 117 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.21349199 |
| 118 | Peroxisome_Homo sapiens_hsa04146 | 0.20685563 |
| 119 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.20603627 |
| 120 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.19878906 |
| 121 | Ribosome_Homo sapiens_hsa03010 | 0.17893981 |
| 122 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.17707854 |
| 123 | Retinol metabolism_Homo sapiens_hsa00830 | 0.17405755 |
| 124 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.17366044 |
| 125 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.16367661 |
| 126 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.16198857 |
| 127 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.15994956 |
| 128 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.14268423 |
| 129 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.14195029 |
| 130 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.14093562 |
| 131 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.13826539 |
| 132 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.12851928 |
| 133 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.11660825 |
| 134 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.10492654 |
| 135 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.08224596 |
| 136 | Phagosome_Homo sapiens_hsa04145 | 0.07351944 |

